Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-18

Clinical Trial Update: Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily Routine

View source ↗

Summary

This completed clinical trial compares long-term use of galantamine versus unspecified memory-enhancing drugs in patients with Alzheimer's dementia under daily …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Galantamine (galantamine)
  • Nootropics (unspecified memory-enhancing drugs)

Snippet

Sponsor: Janssen-Cilag G.m.b.H | Conditions: Dementia, Alzheimer Disease | Status: COMPLETED